Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997;75(4):537-41.
doi: 10.1038/bjc.1997.93.

Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression

Affiliations
Free PMC article

Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression

F Basolo et al. Br J Cancer. 1997.
Free PMC article

Abstract

The aim of this study was to determine the apoptotic cell death in 92 thyroid carcinomas of different histotypes (42 papillary, PTC; 12 poorly differentiated, PDC: 21 undifferentiated, UC; and 17 medullary, MC) by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-digoxigenin nick end labelling (TUNEL). Apoptotic index (Al, evaluated as a percentage of TUNEL-positive cells of neoplastic cells) was calculated in each tumour. The AI was very low in all subtypes of thyroid carcinoma, ranging from a median value of 0.2 in PTC to 1.4 in UC. The proliferative activity was determined by immunohistochemistry using monoclonal antibody, MIB-1. The percentage of proliferating cells was significantly different among the histotypes, increasing with tumour aggressiveness (from the mean value of 3.1 for PTC to 5.6 for PDC and 51.8 for UC). In addition, the ratio between proliferative activity and apoptosis was significantly higher in UC than in the other histotypes. The expression of bcl-2 and p53 protein (important in the modulation of cell death) was correlated (bcl-2, inverse correlation, r2 = 0.1, P = 0.04; p53, direct correlation, r2 = 0.11, P = 0.02) with apoptotic index in PTC.

PubMed Disclaimer

References

    1. Cancer. 1983 Nov 15;52(10):1849-55 - PubMed
    1. Diagn Mol Pathol. 1995 Dec;4(4):235-8 - PubMed
    1. Cell. 1991 Jun 28;65(7):1097-8 - PubMed
    1. J Cell Biol. 1992 Nov;119(3):493-501 - PubMed
    1. J Pathol. 1992 Dec;168(4):357-63 - PubMed

Publication types